Basic Information
Eidos Therapeutics is a new biopharmaceutical company focused on developing small molecule drugs for the treatment of transthyretin (TTR) amyloidosis.
Eidos Therapeutics, Inc.
SanFrancisco,California,United States of America
unclear
August 01, 2013
info@eidostx.com